Literature DB >> 28986833

Expression and X-Ray Structural Determination of the Nucleoprotein of Lassa Fever Virus.

Xiaoxuan Qi1, Wenjian Wang1,2, Haohao Dong1, Yuying Liang3, Changjiang Dong4, Hinh Ly5.   

Abstract

We describe methods to express the nucleoprotein (NP) of Lassa fever virus (LASV) in E. coli, to purify and crystallize it using the sitting-drop vapor diffusion method. The crystals were screened using Rigaku micro-007 X-ray generator and a dataset was collected at a resolution of 2.36 Å. The crystals belong to space group P3, with the unit cell parameters a = b = 176.35 Å, c = 56.40 Å, α = β = 90°, and γ = 120°. Using the X-ray diffraction method, we constructed a three-dimensional structure of the LASV NP that should aid in the development of novel therapeutic strategies against this virus, for which vaccine and effective treatment modalities are currently unavailable.

Entities:  

Keywords:  Arenavirus; Large-scale expression; Lassa virus; Nucleoprotein; X-ray structure

Mesh:

Substances:

Year:  2018        PMID: 28986833      PMCID: PMC6351422          DOI: 10.1007/978-1-4939-6981-4_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 2.  New opportunities for field research on the pathogenesis and treatment of Lassa fever.

Authors:  Sheik Humarr Khan; Augustine Goba; May Chu; Cathy Roth; Tim Healing; Arthur Marx; Joseph Fair; Mary C Guttieri; Philip Ferro; Tiffany Imes; Corina Monagin; Robert F Garry; Daniel G Bausch
Journal:  Antiviral Res       Date:  2007-12-17       Impact factor: 5.970

3.  A fatal case of Lassa fever in London, January 2009.

Authors:  A Kitching; S Addiman; S Cathcart; L Bischop; D Krahé; M Nicholas; J Coakley; G Lloyd; T Brooks; D Morgan; D Turbitt
Journal:  Euro Surveill       Date:  2009-02-12

4.  Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression.

Authors:  Kathryn M Hastie; Christopher R Kimberlin; Michelle A Zandonatti; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

5.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

6.  Imported Lassa fever in Germany: surveillance and management of contact persons.

Authors:  Walter H Haas; Thomas Breuer; Günter Pfaff; Herbert Schmitz; Päivi Köhler; Marcel Asper; Petra Emmerich; Christian Drosten; Uta Gölnitz; Klaus Fleischer; Stephan Günther
Journal:  Clin Infect Dis       Date:  2003-05-09       Impact factor: 9.079

Review 7.  Phylogeny of the genus Arenavirus.

Authors:  Rémi N Charrel; Xavier de Lamballerie; Sébastien Emonet
Journal:  Curr Opin Microbiol       Date:  2008-07-17       Impact factor: 7.934

8.  Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).

Authors:  Robert Eichler; Thomas Strecker; Larissa Kolesnikova; Jan ter Meulen; Winfried Weissenhorn; Stephan Becker; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  Virus Res       Date:  2004-03-15       Impact factor: 3.303

9.  Cap binding and immune evasion revealed by Lassa nucleoprotein structure.

Authors:  Xiaoxuan Qi; Shuiyun Lan; Wenjian Wang; Lisa McLay Schelde; Haohao Dong; Gregor D Wallat; Hinh Ly; Yuying Liang; Changjiang Dong
Journal:  Nature       Date:  2010-11-17       Impact factor: 49.962

10.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.